Harbor Capital Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,113
| Closed | -$2.14M | – | 1390 |
|
|
2025
Q1 | $2.14M | Buy |
53,113
+7,983
| +18% | +$321K | 0.1% | 274 |
|
|
2024
Q4 | $2.12M | Buy |
45,130
+2,604
| +6% | +$122K | 0.09% | 267 |
|
|
2024
Q3 | $2.25M | Buy |
42,526
+24,712
| +139% | +$1.3M | 0.1% | 282 |
|
|
2024
Q2 | $965K | Buy |
17,814
+14,270
| +403% | +$773K | 0.07% | 365 |
|
|
2024
Q1 | $248K | Buy |
+3,544
| New | +$248K | 0.03% | 558 |
|
|
2023
Q3 | – | Sell |
-722
| Closed | -$23.6K | – | 497 |
|
|
2023
Q2 | $23.6K | Buy |
+722
| New | +$23.6K | ﹤0.01% | 570 |
|